ICOSLG and cancer: It was originally thought to be limited to the T-cell activation phase and T-cell-dependent B-cell response [12]; however, in recent studies, the interaction between ICOS and ICOSL has been shown to play a role in the downstream survival and expansion of T cells (effectors and modulators) and thus could influence the immune-mediated cancer tolerance [13, 14].